Ranbaxy, Cipla & Glaxo to co-market anti-anthrax drug
Pharma giants -Glaxo, Cipla and Ranbaxy -have entered into a co-marketing alliance for the Ranbaxy's anti-anthrax drug 'ciprofloxacin' the once-a-day anti-bacterial dosage form from the company's
Pharma giants -Glaxo, Cipla and Ranbaxy -have entered into a co-marketing alliance for the Ranbaxy's anti-anthrax drug 'ciprofloxacin' the once-a-day anti-bacterial dosage form from the company's